Skip to main content
Erschienen in: European Archives of Oto-Rhino-Laryngology 2/2019

10.12.2018 | Head & Neck

Central compartment revision surgery for persistent or recurrent thyroid carcinoma: analysis of survival and complication rate

verfasst von: Gabriele Molteni, Marco Bonali, Francesco Mattioli, Michael Ghirelli, Matteo Fermi, Gaetano Ferri, Malagoli Andrea, Livio Presutti

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Locoregional recurrence of thyroid carcinoma is relatively common and reported rate are between 5 and 20%. Cervical nodes are usually involved, especially at the central compartment. The management of recurrent thyroid carcinoma at central compartment still remains challenging because of higher incidence of complication rate. The aim of the study is to evaluate the survival and complications rate after revision surgery.

Methods

Retrospective cohort study on a group of patients that underwent revision surgery for persistent or recurrent thyroid carcinoma from January 1, 2003 to December 31, 2017. Survival outcomes were calculated using Kaplan–Meier method. Significant variables on univariate analysis were subjected to a Cox proportional hazards regression multivariate model.

Results

Fifty-two patients involved, 22 male (40%) and 30 female (60%). Mean age was 54 years old (range 24–85). Mean follow-up was 79 months, median follow-up was 85 months, with a range between 8 and 153 months. The 5-year overall survival was 90.8% while at 10 years it was 69.8%. The 5-year disease-specific survival was 93.5%, while at 10 years it dropped to 77.9%. The rate of recurrent laryngeal nerve paralysis and persistent hypocalcemia in our series were 1.3% and 5.9%, respectively. No evidence of thoracic duct, esophageal or laryngeal and tracheal injury was found in this case series. Regarding prognostic factors, univariate and multivariate analysis highlighted as statistically significant: the aggressive histological variants, the presence extranodal extension or soft-tissue metastasis.

Conclusion

The surgical option remains the gold standard in locoregional recurrences of thyroid carcinoma and should be performed by experienced surgeons to reduce postoperative complications.
Literatur
1.
Zurück zum Zitat Kist JW, de Keizer B, Stokkel MPM, Hoekstra OS, Vogel WV, THYROPET Study Group (2014) Recurrent differentiated thyroid cancer: towards personalized treatment based on evaluation of tumor characteristics with PET (THYROPET Study): study protocol of a multicenter observational cohort study. BMC Cancer 14:405CrossRefPubMedPubMedCentral Kist JW, de Keizer B, Stokkel MPM, Hoekstra OS, Vogel WV, THYROPET Study Group (2014) Recurrent differentiated thyroid cancer: towards personalized treatment based on evaluation of tumor characteristics with PET (THYROPET Study): study protocol of a multicenter observational cohort study. BMC Cancer 14:405CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Schvartz C, Bonnetain F, Dabakuyo S et al (2012) Impact on overall survival of radioactive iodine in low-risk differentiated thyroid cancer patients. J Clin Endocrinol Metab 97(5):1526–1535CrossRefPubMed Schvartz C, Bonnetain F, Dabakuyo S et al (2012) Impact on overall survival of radioactive iodine in low-risk differentiated thyroid cancer patients. J Clin Endocrinol Metab 97(5):1526–1535CrossRefPubMed
3.
Zurück zum Zitat Welsh L, Powell C, Pratt B et al (2013) Long-term outcomes following low-dose radioiodide ablation for differentiated thyroid cancer. J Clin Endocrinol Metab 98(5):1819–1825CrossRefPubMed Welsh L, Powell C, Pratt B et al (2013) Long-term outcomes following low-dose radioiodide ablation for differentiated thyroid cancer. J Clin Endocrinol Metab 98(5):1819–1825CrossRefPubMed
4.
5.
Zurück zum Zitat Schlumberger M, Challeton C, De Vathaire F et al (1996) Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. J Nucl Med 37(4):598–605PubMed Schlumberger M, Challeton C, De Vathaire F et al (1996) Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. J Nucl Med 37(4):598–605PubMed
6.
Zurück zum Zitat Amit M, Tam S, Boonsripitayanon M et al (2018) Association of lymph node density with survival of patients with papillary thyroid cancer. JAMA Otolaryngol Head Neck Surg 144(2):108–114CrossRefPubMed Amit M, Tam S, Boonsripitayanon M et al (2018) Association of lymph node density with survival of patients with papillary thyroid cancer. JAMA Otolaryngol Head Neck Surg 144(2):108–114CrossRefPubMed
7.
Zurück zum Zitat Higgins TS, Gupta R, Ketcham AS, Sataloff RT, Wadsworth JT, Sinacori JT (2011) Recurrent laryngeal nerve monitoring versus identification alone on post-thyroidectomy true vocal fold palsy: a meta-analysis. Laryngoscope 121(5):1009–1017CrossRefPubMed Higgins TS, Gupta R, Ketcham AS, Sataloff RT, Wadsworth JT, Sinacori JT (2011) Recurrent laryngeal nerve monitoring versus identification alone on post-thyroidectomy true vocal fold palsy: a meta-analysis. Laryngoscope 121(5):1009–1017CrossRefPubMed
8.
Zurück zum Zitat Orloff LA, Wiseman SM, Bernet VJ et al (2018) American thyroid association statement on postoperative hypoparathyroidism: diagnosis, prevention, and management in adults. Thyroid 28(7):830–841CrossRefPubMed Orloff LA, Wiseman SM, Bernet VJ et al (2018) American thyroid association statement on postoperative hypoparathyroidism: diagnosis, prevention, and management in adults. Thyroid 28(7):830–841CrossRefPubMed
9.
Zurück zum Zitat McMullen C, Rocke D, Freeman J (2017) Complications of bilateral neck dissection in thyroid cancer from a single high-volume center. JAMA Otolaryngol Head Neck Surg 143(4):376–381CrossRefPubMed McMullen C, Rocke D, Freeman J (2017) Complications of bilateral neck dissection in thyroid cancer from a single high-volume center. JAMA Otolaryngol Head Neck Surg 143(4):376–381CrossRefPubMed
10.
Zurück zum Zitat Clayman GL, Agarwal G, Edeiken BS, Waguespack SG, Roberts DB, Sherman SI (2011) Long-term outcome of comprehensive central compartment dissection in patients with recurrent/persistent papillary thyroid carcinoma. Thyroid 21(12):1309–1316CrossRefPubMedPubMedCentral Clayman GL, Agarwal G, Edeiken BS, Waguespack SG, Roberts DB, Sherman SI (2011) Long-term outcome of comprehensive central compartment dissection in patients with recurrent/persistent papillary thyroid carcinoma. Thyroid 21(12):1309–1316CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Magarey MJR, Freeman JL (2013) Recurrent well-differentiated thyroid carcinoma. Oral Oncol 49(7):689–694CrossRefPubMed Magarey MJR, Freeman JL (2013) Recurrent well-differentiated thyroid carcinoma. Oral Oncol 49(7):689–694CrossRefPubMed
12.
Zurück zum Zitat Lang BH-H, Lee GCC, Ng CPC, Wong KP, Wan KY, Lo C-Y (2013) Evaluating the morbidity and efficacy of reoperative surgery in the central compartment for persistent/recurrent papillary thyroid carcinoma. World J Surg 37(12):2853–2859CrossRefPubMed Lang BH-H, Lee GCC, Ng CPC, Wong KP, Wan KY, Lo C-Y (2013) Evaluating the morbidity and efficacy of reoperative surgery in the central compartment for persistent/recurrent papillary thyroid carcinoma. World J Surg 37(12):2853–2859CrossRefPubMed
13.
Zurück zum Zitat Clayman GL, Shellenberger TD, Ginsberg LE et al (2009) Approach and safety of comprehensive central compartment dissection in patients with recurrent papillary thyroid carcinoma. Head Neck 31(9):1152–1163CrossRefPubMed Clayman GL, Shellenberger TD, Ginsberg LE et al (2009) Approach and safety of comprehensive central compartment dissection in patients with recurrent papillary thyroid carcinoma. Head Neck 31(9):1152–1163CrossRefPubMed
14.
Zurück zum Zitat Sherman SI, Angelos P, Ball DW et al (2005) Thyroid carcinoma. J Natl Compr Canc Netw 3(3):404–457CrossRefPubMed Sherman SI, Angelos P, Ball DW et al (2005) Thyroid carcinoma. J Natl Compr Canc Netw 3(3):404–457CrossRefPubMed
15.
Zurück zum Zitat Schuff KG, Weber SM, Givi B, Samuels MH, Andersen PE, Cohen JI (2008) Efficacy of nodal dissection for treatment of persistent/recurrent papillary thyroid cancer. The Laryngoscope 118(5):768–775CrossRefPubMed Schuff KG, Weber SM, Givi B, Samuels MH, Andersen PE, Cohen JI (2008) Efficacy of nodal dissection for treatment of persistent/recurrent papillary thyroid cancer. The Laryngoscope 118(5):768–775CrossRefPubMed
17.
Zurück zum Zitat Hughes DT, Laird AM, Miller BS, Gauger PG, Doherty GM (2012) Reoperative lymph node dissection for recurrent papillary thyroid cancer and effect on serum thyroglobulin. Ann Surg Oncol 19(9):2951–2957CrossRefPubMed Hughes DT, Laird AM, Miller BS, Gauger PG, Doherty GM (2012) Reoperative lymph node dissection for recurrent papillary thyroid cancer and effect on serum thyroglobulin. Ann Surg Oncol 19(9):2951–2957CrossRefPubMed
18.
Zurück zum Zitat Shah MD, Harris LD, Nassif RG, Kim D, Eski S, Freeman JL (2012) Efficacy and safety of central compartment neck dissection for recurrent thyroid carcinoma. Arch Otolaryngol Head Neck Surg 138(1):33–37CrossRefPubMed Shah MD, Harris LD, Nassif RG, Kim D, Eski S, Freeman JL (2012) Efficacy and safety of central compartment neck dissection for recurrent thyroid carcinoma. Arch Otolaryngol Head Neck Surg 138(1):33–37CrossRefPubMed
19.
Zurück zum Zitat Cayonu M, Acar A, Eryilmaz A, Oguz O (2014) Surgical approach and outcomes for revision surgery of the central neck compartment. J Craniofac Surg 25(5):1797–1800CrossRefPubMed Cayonu M, Acar A, Eryilmaz A, Oguz O (2014) Surgical approach and outcomes for revision surgery of the central neck compartment. J Craniofac Surg 25(5):1797–1800CrossRefPubMed
20.
Zurück zum Zitat Barczyński M, Konturek A, Cichoń S (2009) Randomized clinical trial of visualization versus neuromonitoring of recurrent laryngeal nerves during thyroidectomy. Br J Surg 96(3):240–246CrossRefPubMed Barczyński M, Konturek A, Cichoń S (2009) Randomized clinical trial of visualization versus neuromonitoring of recurrent laryngeal nerves during thyroidectomy. Br J Surg 96(3):240–246CrossRefPubMed
21.
Zurück zum Zitat Randolph GW, Dralle H, International Intraoperative Monitoring Study Group et al (2011) Electrophysiologic recurrent laryngeal nerve monitoring during thyroid and parathyroid surgery: international standards guideline statement. Laryngoscope 121(Suppl 1):S1–S16CrossRefPubMed Randolph GW, Dralle H, International Intraoperative Monitoring Study Group et al (2011) Electrophysiologic recurrent laryngeal nerve monitoring during thyroid and parathyroid surgery: international standards guideline statement. Laryngoscope 121(Suppl 1):S1–S16CrossRefPubMed
22.
Zurück zum Zitat Kim MK, Mandel SH, Baloch Z et al (2004) Morbidity following central compartment reoperation for recurrent or persistent thyroid cancer. Arch Otolaryngol Head Neck Surg 130(10):1214–1216CrossRefPubMed Kim MK, Mandel SH, Baloch Z et al (2004) Morbidity following central compartment reoperation for recurrent or persistent thyroid cancer. Arch Otolaryngol Head Neck Surg 130(10):1214–1216CrossRefPubMed
23.
Zurück zum Zitat Farrag TY, Agrawal N, Sheth S et al (2007) Algorithm for safe and effective reoperative thyroid bed surgery for recurrent/persistent papillary thyroid carcinoma. Head Neck 29(12):1069–1074CrossRefPubMed Farrag TY, Agrawal N, Sheth S et al (2007) Algorithm for safe and effective reoperative thyroid bed surgery for recurrent/persistent papillary thyroid carcinoma. Head Neck 29(12):1069–1074CrossRefPubMed
24.
Zurück zum Zitat Alvarado R, Sywak MS, Delbridge L, Sidhu SB (2009) Central lymph node dissection as a secondary procedure for papillary thyroid cancer: is there added morbidity? Surgery 145(5):514–518CrossRefPubMed Alvarado R, Sywak MS, Delbridge L, Sidhu SB (2009) Central lymph node dissection as a secondary procedure for papillary thyroid cancer: is there added morbidity? Surgery 145(5):514–518CrossRefPubMed
25.
Zurück zum Zitat Ondik MP, Dezfoli S, Lipinski L, Ruggiero F, Goldenberg D (2009) Secondary central compartment surgery for thyroid cancer. Laryngoscope 119(10):1947–1950CrossRefPubMed Ondik MP, Dezfoli S, Lipinski L, Ruggiero F, Goldenberg D (2009) Secondary central compartment surgery for thyroid cancer. Laryngoscope 119(10):1947–1950CrossRefPubMed
26.
Zurück zum Zitat Shen WT, Ogawa L, Ruan D et al (2010) Central neck lymph node dissection for papillary thyroid cancer: comparison of complication and recurrence rates in 295 initial dissections and reoperations. Arch Surg 145(3):272–275CrossRefPubMed Shen WT, Ogawa L, Ruan D et al (2010) Central neck lymph node dissection for papillary thyroid cancer: comparison of complication and recurrence rates in 295 initial dissections and reoperations. Arch Surg 145(3):272–275CrossRefPubMed
27.
Zurück zum Zitat Roh J-L, Kim J-M, Park CI (2011) Central compartment reoperation for recurrent/persistent differentiated thyroid cancer: patterns of recurrence, morbidity, and prediction of postoperative hypocalcemia. Ann Surg Oncol 18(5):1312–1318CrossRefPubMed Roh J-L, Kim J-M, Park CI (2011) Central compartment reoperation for recurrent/persistent differentiated thyroid cancer: patterns of recurrence, morbidity, and prediction of postoperative hypocalcemia. Ann Surg Oncol 18(5):1312–1318CrossRefPubMed
28.
Zurück zum Zitat Bergamini G, Alicandri-Ciufelli M, Molteni G (2010) Therapy of unilateral vocal fold paralysis with polydimethylsiloxane injection laryngoplasty: our experience. J Voice 24(1):119–125CrossRefPubMed Bergamini G, Alicandri-Ciufelli M, Molteni G (2010) Therapy of unilateral vocal fold paralysis with polydimethylsiloxane injection laryngoplasty: our experience. J Voice 24(1):119–125CrossRefPubMed
29.
Zurück zum Zitat Mattioli F, Bettini M, Botti C et al (2017) Polydimethylsiloxane injection laryngoplasty for unilateral vocal fold paralysis: long-term results. J Voice 31(4):517.e1–517.e7CrossRef Mattioli F, Bettini M, Botti C et al (2017) Polydimethylsiloxane injection laryngoplasty for unilateral vocal fold paralysis: long-term results. J Voice 31(4):517.e1–517.e7CrossRef
Metadaten
Titel
Central compartment revision surgery for persistent or recurrent thyroid carcinoma: analysis of survival and complication rate
verfasst von
Gabriele Molteni
Marco Bonali
Francesco Mattioli
Michael Ghirelli
Matteo Fermi
Gaetano Ferri
Malagoli Andrea
Livio Presutti
Publikationsdatum
10.12.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Oto-Rhino-Laryngology / Ausgabe 2/2019
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-018-5239-2

Weitere Artikel der Ausgabe 2/2019

European Archives of Oto-Rhino-Laryngology 2/2019 Zur Ausgabe

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.